Potential impact of the antirheumatic agent auranofin on proviral HIV-1 DNA in individuals under intensified antiretroviral therapy: Results from a randomised clinical trial

SPARC Working Group

Research output: Contribution to journal › Article (Academic Journal) › peer-review

33 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Potential impact of the antirheumatic agent auranofin on proviral HIV-1 DNA in individuals under intensified antiretroviral therapy: Results from a randomised clinical trial'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science